AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33378750 — intervention group
Group type: EXPERIMENTAL
Intervention: CHL-PRED
Number of subjects: 69
Study 33378750 — intervention group
Group type: EXPERIMENTAL
Intervention: CHL
Number of subjects: 69
Study 33378750 — intervention group
Group type: COMPARATOR
Intervention: AQUA
Number of subjects: 69
Study 35293367 — intervention group
Group type: EXPERIMENTAL
Intervention: Work participation after 1 year
Number of subjects: 116
Study 33554745 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) with demonstrations and pictorial instructions
Number of subjects: 637
Study 33554745 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 637
Study 32527676 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality based cognitive behavioral therapy (VR‐CBT)
Number of subjects: 91
Study 32527676 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 91
Study 34806929 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine administration
Number of subjects: 2
Study 33839552 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (inhalation)
Number of subjects: 16
Study 33839552 — intervention group
Group type: COMPARATOR
Intervention: Aromatherapy (massage)
Number of subjects: 16
Study 35253448 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium citrate (450 mg/d)
Number of subjects: 164
Study 35253448 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium oxide (450 mg/d)
Number of subjects: 164
Study 35253448 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (450 mg/d)
Number of subjects: 164
Study 35253448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 32173961 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte subsets (neutrophils, lymphocytes, monocytes, basophils) in men with AAA
Number of subjects: 375
Study 32173961 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophils
Number of subjects: 375
Study 32173961 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocytes
Number of subjects: 375
Study 32173961 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocytes
Number of subjects: 375
Study 32173961 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophils and lymphocytes
Number of subjects: 375
Study 32173961 — intervention group
Group type: COMPARATOR
Intervention: Control group (AAA-free men)
Number of subjects: 375
Study 616063536 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib/Carboplatin (VC)
Number of subjects: 116
Study 616063536 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 116
Study 35218628 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinggan Jiangya decoction combined with penetrating needling at Baihui (GV20) once daily for 8 weeks
Number of subjects: 150
Study 35218628 — intervention group
Group type: COMPARATOR
Intervention: Pinggan Jiangya decoction once daily for 8 weeks
Number of subjects: 150
Study 33096497 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-trained, family member-delivered rehabilitation model
Number of subjects: 61
Study 33096497 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 61
Study 36468948 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 100
Study 36468948 — intervention group
Group type: COMPARATOR
Intervention: Control group (general rehabilitation programs)
Number of subjects: 100
Study 33418362 — intervention group
Group type: EXPERIMENTAL
Intervention: CADSS-6 (6-item version of the Clinician-Administered Dissociative States Scale)
Number of subjects: 260
Study 33415915 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) as add-on treatment
Number of subjects: 120
Study 35739551 — intervention group
Group type: EXPERIMENTAL
Intervention: E-SEE Steps intervention
Number of subjects: 339
Study 33751652 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal oral hygiene (pOH) at daily intervals (12-24 hours)
Number of subjects: 42
Study 33751652 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal oral hygiene (pOH) at extended intervals (48 hours)
Number of subjects: 42
Study 32012323 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - school-based intervention for increasing physical activity and reducing sedentary time
Number of subjects: 597
Study 32012323 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - school-based intervention
Number of subjects: 597
Study 32012323 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - no intervention
Number of subjects: 597
Study 34429224 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone with particulate acemannan (mean size 32.45 μm)
Number of subjects: 20
Study 34429224 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized bovine bone only
Number of subjects: 20
Study 35124915 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional vitamin D3
Number of subjects: 50
Study 35124915 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 50
Study 35244717 — intervention group
Group type: EXPERIMENTAL
Intervention: Kisspeptin administration
Number of subjects: 26
Study 35244717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 33288408 — intervention group
Group type: COMPARATOR
Intervention: Single vision silicone hydrogel contact lenses (control lens)
Number of subjects: 379
Study 33288408 — intervention group
Group type: EXPERIMENTAL
Intervention: Two anti-myopia silicone hydrogel contact lenses (test lens I and II)
Number of subjects: 379
Study 33288408 — intervention group
Group type: EXPERIMENTAL
Intervention: Two extended depth of focus hydrogel contact lenses (test lens III and IV)
Number of subjects: 379
Study 33288408 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-adherent wearers (all lens types)
Number of subjects: 379
Study 33288408 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with non-adherence
Number of subjects: 379
Study 33197941 — intervention group
Group type: EXPERIMENTAL
Intervention: 19G Flex needle
Number of subjects: 250
Study 33197941 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G needle
Number of subjects: 250
Study 33197941 — intervention group
Group type: COMPARATOR
Intervention: 19G needle
Number of subjects: 250
Study 33197941 — intervention group
Group type: EXPERIMENTAL
Intervention: All needles
Number of subjects: 250
Study 33197941 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyst aspirate diagnostic accuracy
Number of subjects: 250
Study 33197941 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 250
Study 32553888 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxic HIIT (HHIIT)
Number of subjects: 16
Study 32553888 — intervention group
Group type: COMPARATOR
Intervention: Normoxic HIIT (NHIIT)
Number of subjects: 16
Study 36150995 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiogram parameters used for predicting surgery eligibility
Number of subjects: 1785
Study 36150995 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoring system based on echocardiogram parameters
Number of subjects: 1785
Study 32663928 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly derived Hamilton depression scale measures (9-item and 4-item scales)
Number of subjects: 5
Study 32663928 — intervention group
Group type: COMPARATOR
Intervention: Total Hamilton depression measure
Number of subjects: 5
Study 34737211 — intervention group
Group type: EXPERIMENTAL
Intervention: FBXW7 knockout
Number of subjects: 0
Study 34737211 — intervention group
Group type: EXPERIMENTAL
Intervention: FBXW7 deletion
Number of subjects: 0
Study 34737211 — intervention group
Group type: EXPERIMENTAL
Intervention: FBXW7 deficiency
Number of subjects: 0
Study 34949098 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PRS) for coronary heart disease (CHD)
Number of subjects: 12792
Study 34949098 — intervention group
Group type: COMPARATOR
Intervention: Conventional risk factors
Number of subjects: 12792
Study 34949098 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PRS) added to conventional risk factors
Number of subjects: 12792
Study 32330775 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 39
Study 32330775 — intervention group
Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 39
Study 32459394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun Safety Schools (SSS) intervention
Number of subjects: 118
Study 32459394 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents receiving sun safety information
Number of subjects: 118
Study 32459394 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 118
Study 35773604 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS+ group (guideline-based ERAS protocol)
Number of subjects: 118
Study 35773604 — intervention group
Group type: COMPARATOR
Intervention: ERAS- group (standard care)
Number of subjects: 118
Study 34506358 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily mobile reporting
Number of subjects: 30
Study 34506358 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily swabbing arm
Number of subjects: 30
Study 34506358 — intervention group
Group type: COMPARATOR
Intervention: YSTR mixtures
Number of subjects: 30
Study 34506358 — intervention group
Group type: COMPARATOR
Intervention: Detection of HIV‐1 total nucleic acids
Number of subjects: 30
Study 33212256 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir (1800 mg BID on day 1 and 800 mg BID from days 2-14) plus standard supportive care
Number of subjects: 150
Study 33212256 — intervention group
Group type: COMPARATOR
Intervention: Control (supportive care alone)
Number of subjects: 150
Study 35086209 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac 0.3%
Number of subjects: 470
Study 35086209 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1%
Number of subjects: 470
Study 35086209 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (including nepafenac 0.1%, bromfenac 0.07%, preservative-free ketorolac 0.4%, nepafenac 0.3%)
Number of subjects: 470
Study 36462528 — intervention group
Group type: EXPERIMENTAL
Intervention: Single low-dose primaquine combined with artemether-lumefantrine
Number of subjects: 1137
Study 36462528 — intervention group
Group type: EXPERIMENTAL
Intervention: Single low-dose primaquine combined with dihydroartemisinin-piperaquine
Number of subjects: 1137
Study 36462528 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with artemether-lumefantrine
Number of subjects: 1137
Study 36462528 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with dihydroartemisinin-piperaquine
Number of subjects: 1137
Study 35639381 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed educational materials to patients and/or clinicians
Number of subjects: 47333
Study 35639381 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 47333
Study 36195683 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercaloric diet (25% increase of energy intake by fat)
Number of subjects: 20
Study 36195683 — intervention group
Group type: COMPARATOR
Intervention: Normocaloric diet
Number of subjects: 20
Study 36195683 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercaloric diet
Number of subjects: 20
Study 33752738 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention from the LipiDiDiet study
Number of subjects: 0
Study 33339438 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients, lutein, and docosahexaenoic acid (DHA) supplementation
Number of subjects: 70
Study 33339438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 616038045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 2.0mg
Number of subjects: 119
Study 616038045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5mg
Number of subjects: 119
Study 616038045 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-involving DME
Number of subjects: 119
Study 616038045 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined center + non-center involving DME
Number of subjects: 119
Study 616038045 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent DME
Number of subjects: 119
Study 616038045 — intervention group
Group type: EXPERIMENTAL
Intervention: SRF presence
Number of subjects: 119
Study 32045734 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help exercise program (flexibility, range-of-motion and lymphedema exercises and self-care education program)
Number of subjects: 92
Study 32045734 — intervention group
Group type: COMPARATOR
Intervention: Control group (self-care education program)
Number of subjects: 92
Study 35051321 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composite group (Filtek Z350 XT)
Number of subjects: 30
Study 35051321 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer group (RMGI) (Vitremer Tricure)
Number of subjects: 30
Study 35051321 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DME)
Number of subjects: 30
Study 35021200 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 6632
Study 35021200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6632
Study 32037149 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin 200 mg/kg/day for 8 weeks
Number of subjects: 414
Study 32037149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 414
Study 32037149 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin
Number of subjects: 414
Study 33558347 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam
Number of subjects: 1084
Study 33558347 — intervention group
Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 1084
Study 33060432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) ketamine 0.5 mg/kg
Number of subjects: 45
Study 33060432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine 1 mg/kg
Number of subjects: 45
Study 33060432 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT)
Number of subjects: 45
Study 36271428 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal chiropractic care including spinal manipulation, education, exercise, self-management advice, and myofascial therapies over 8 weeks, twice weekly sessions
Number of subjects: 20
Study 36271428 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal chiropractic care
Number of subjects: 20
Study 33615628 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS0313 (9 mg)
Number of subjects: 17
Study 33615628 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS0313 (27 mg)
Number of subjects: 17
Study 33615628 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS0313 (9 mg and 27 mg)
Number of subjects: 17
Study 35120861 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile, kinesthetic and oral stimulation (T + K + OS)
Number of subjects: 42
Study 35120861 — intervention group
Group type: COMPARATOR
Intervention: Oral stimulation (OS)
Number of subjects: 42
Study 34024541 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual‐Energy X‐Ray Absorptiometry (DXA)
Number of subjects: 66
Study 34024541 — intervention group
Group type: EXPERIMENTAL
Intervention: Single CT slice at L3-level
Number of subjects: 66
Study 34024541 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of three CT slices (L2, L3, L4)
Number of subjects: 66
Study 34024541 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometric measurements
Number of subjects: 66
Study 34953290 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE)
Number of subjects: 120
Study 34953290 — intervention group
Group type: COMPARATOR
Intervention: Biomedical-focused neck/back school (control)
Number of subjects: 120
Study 34537926 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 836
Study 34537926 — intervention group
Group type: COMPARATOR
Intervention: ESA
Number of subjects: 836
Study 36450426 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice nurse‐led preventive health check, a mobile application and telephone coaching
Number of subjects: 215
Study 36450426 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 215
Study 33983124 — intervention group
Group type: EXPERIMENTAL
Intervention: NoteAid intervention (n=89)
Number of subjects: 174
Study 33983124 — intervention group
Group type: EXPERIMENTAL
Intervention: NoteAid intervention (n=100 from AMT)
Number of subjects: 174
Study 33983124 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=85 from LGH)
Number of subjects: 174
Study 33983124 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=100 from AMT)
Number of subjects: 174
Study 33983124 — intervention group
Group type: EXPERIMENTAL
Intervention: Community hospital participants
Number of subjects: 174
Study 33397432 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I nasal irrigation at 0.4%
Number of subjects: 189
Study 33397432 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I nasal irrigation at 0.5%
Number of subjects: 189
Study 33397432 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I nasal irrigation at 0.6%
Number of subjects: 189
Study 33397432 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I nasal spray at 0.5%
Number of subjects: 189
Study 33397432 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP-I nasal spray at 0.6%
Number of subjects: 189
Study 33397432 — intervention group
Group type: COMPARATOR
Intervention: Distilled water through nasal irrigation (placebo)
Number of subjects: 189
Study 33397432 — intervention group
Group type: COMPARATOR
Intervention: Distilled water through nasal spray (placebo)
Number of subjects: 189
Study 35830988 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose low-molecular-weight-heparin (LMWH) therapy
Number of subjects: 164
Study 35830988 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose low-molecular-weight-heparin (LMWH) therapy
Number of subjects: 164
Study 35830988 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose low-molecular-weight-heparin (LMWH) with aspirin
Number of subjects: 164
Study 33538643 — intervention group
Group type: EXPERIMENTAL
Intervention: Previsit phone call from an orthopedic surgeon
Number of subjects: 122
Study 33538643 — intervention group
Group type: COMPARATOR
Intervention: No previsit phone call (control group)
Number of subjects: 122
Study 35503305 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT Intervention for Trauma Patients (SITP) - a 15-minute session with elements of cognitive behavioral therapy techniques
Number of subjects: 46
Study 35503305 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 46
Study 33671968 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics stimulation (34 patients)
Number of subjects: 69
Study 33671968 — intervention group
Group type: COMPARATOR
Intervention: Control group (35 patients)
Number of subjects: 69
Study 34294494 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week nurse-led health coaching programme
Number of subjects: 140
Study 34294494 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 140
Study 33892832 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride plus hydroxyapatite (Remin Pro®; RP)
Number of subjects: 0
Study 33892832 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride plus casein phosphopeptide‐amorphous calcium phosphate fluoride (Mi Paste Plus®; MPP)
Number of subjects: 0
Study 33892832 — intervention group
Group type: COMPARATOR
Intervention: Colgate Total®; CT (Control)
Number of subjects: 0
Study 34791348 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI (kg/m2)
Number of subjects: 304
Study 34791348 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat mass index (FMI: kg/m2)
Number of subjects: 304
Study 34791348 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean mass index (LMI; kg/m2)
Number of subjects: 304
Study 32325161 — intervention group
Group type: EXPERIMENTAL
Intervention: Veterans with MS who died by suicide
Number of subjects: 426
Study 32325161 — intervention group
Group type: COMPARATOR
Intervention: Randomly selected nonsuicide MS controls
Number of subjects: 426
Study 35680456 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrodiagnostic tests (EDx) recommended by surgeons
Number of subjects: 91
Study 35680456 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort level of surgeons offering carpal tunnel release (CTR) without EDx
Number of subjects: 91
Study 35680456 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons ordering EDx for patient scenarios
Number of subjects: 91
Study 35680456 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with lower likelihood of EDx
Number of subjects: 91
Study 35680456 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with greater surgeon comfort offering CTR without EDx
Number of subjects: 91
Study 32921503 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-HMB supplementation (2 servings/day for up to 90 days)
Number of subjects: 214
Study 32921503 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-HMB supplementation
Number of subjects: 214
Study 32921503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 32199490 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 0
Study 32199490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34734674 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity physical education (HIPE)
Number of subjects: 120
Study 34734674 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HIPE and LIPE (PLUS)
Number of subjects: 120
Study 34734674 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-moderate intensity physical education (LIPE)
Number of subjects: 120
Study 34734674 — intervention group
Group type: COMPARATOR
Intervention: Standard physical education lessons (CTRL)
Number of subjects: 120
Study 35154365 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative oxygenation (SpO2 88–92%)
Number of subjects: 34
Study 35154365 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control – SpO2 ≥96%)
Number of subjects: 34